Tempus AI (NASDAQ:TEM) Stock Price Down 3.6% on Insider Selling

Shares of Tempus AI, Inc. (NASDAQ:TEM) traded down 3.6% during trading on Thursday following insider selling activity. The stock traded as low as $36.72 and last traded at $37.49. 2,982,685 shares changed hands during mid-day trading, a decline of 21% from the average session volume of 3,784,073 shares. The stock had previously closed at $38.88.

Specifically, COO Ryan Fukushima sold 20,000 shares of the stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $39.61, for a total value of $792,200.00. Following the completion of the sale, the chief operating officer now directly owns 982,442 shares of the company’s stock, valued at approximately $38,914,527.62. This represents a 2.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Wall Street Analyst Weigh In

TEM has been the subject of a number of recent analyst reports. Guggenheim began coverage on shares of Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 price target for the company. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the stock from $45.00 to $65.00 in a research note on Monday, November 11th. Piper Sandler restated a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Wolfe Research initiated coverage on Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Finally, Loop Capital lifted their target price on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $56.00.

Tempus AI Stock Performance

The stock has a 50 day simple moving average of $48.45 and a 200-day simple moving average of $46.89. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of TEM. Federated Hermes Inc. bought a new position in Tempus AI during the second quarter valued at $19,886,000. Revolution Growth Management Company Inc. purchased a new position in Tempus AI in the second quarter worth about $128,133,000. Allen Operations LLC bought a new stake in Tempus AI during the second quarter worth approximately $3,831,000. WINTON GROUP Ltd bought a new stake in Tempus AI during the second quarter worth approximately $634,000. Finally, Massachusetts Financial Services Co. MA purchased a new stake in Tempus AI during the second quarter valued at approximately $28,246,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.